Pathway to Stop Diabetes

Funding Agency:
American Diabetes Association

Pathway to Stop Diabetes is a bold, innovative initiative designed to radically transform diabetes research. Our Vision is simple yet revolutionary: find a new generation of brilliant scientists at the peak of their creativity, and provide them with freedom, autonomy, and the financial and professional resources to set them on the road to breakthrough discoveries.

This initiative enables scientists to advance not only their research, but also their careers. Pathway scientists have access to the Mentor Advisory Group, an annual Pathway symposia, select speaking opportunities, and innovative technologies, all designed to foster interactions and collaboration that will enable them to accelerate their research progress.

Pathway seeks to bring new investigators and new perspectives to diabetes research. Supporting scientists with different backgrounds and experience is critical to achieving that objective. Pathway accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication. Pathway solicits nominations for candidates in all disciplines as applied to diabetes including medicine, biology, chemistry, computing, physics, mathematics and engineering. In addition, nomination of scientists from diverse backgrounds, including minority groups that are underrepresented in biomedical research, is strongly encouraged.  

Submissions will be accepted by institutional nomination only.Each institution is allowed a maximum of one nomination per grant cycle. The nomination can be for one of the Pathway Program Award types: Initiator, Accelerator or Visionary. Appropriate institutional representatives must complete a Nomination Form and provide an Institutional Nomination Letter (see Sponsoring Institution Stipulations requirements in Award Guidelines, section II.C). All nomination materials must be submitted at the time of application.

Deadlines:

  • Duke Internal: May 1, 2019
  • Application: July 1, 2019

If the internal deadline has passed and you are interested in this opportunity, please email Anastasia Maddox at fundopps@duke.edu to find out if it is still open.

Agency Website

Areas of Interest

Pathway seeks exceptional nominees from a broad range of disciplines, including medicine, biology, chemistry, engineering, mathematics and physics.

Eligibility Requirements

Below is a brief summary of the eligibility requirements. Please read the FULL requirements on the American Diabetes Association site: https://professional.diabetes.org/meetings/pathway-stop-diabetes%C2%AE

Initiator: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Accelerator: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Visionary: Applicants must be established investigators with exceptional productivity in fields other than diabetes research who would like to apply their expertise to innovative diabetes-related research topics. Applicants must hold faculty positions and have demonstrated independent productivity. Applicants cannot have previously received national grant support (NIH, NIDDK, ADA, JDRF, etc.), as either a PI or Co-PI, in diabetesor diabetes-related research.

Amount

$1,625,000

Amount Description

Initiator Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.

The Pathway Accelerator Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.

The Pathway Visionary Awards provide two distinct phases of research support: Phase 1 provides up to three years of support at a maximum of $325,000 per year (including 30% indirect costs), Phase 2 provides up to two years of support at a maximum of $325,000 per year (including 30% indirect costs). Phase 2 renewal is contingent upon demonstration of significant contributions to the field of diabetes research in Phase 1. Maximum combined support for Phase 1 and Phase 2 is $1,625,000. 

Funding Type

Grant

Eligibility

Junior Faculty
Medical Fellow/Resident
Post Doctoral Fellows

Category

Engineering and Physical Sciences
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

Internal Nomination

Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials as one PDF. If the Chair wishes for their letter to be kept confidential, it can be emailed to Anastasia Maddox at amm39@duke.edu.

* NIH Biosketch
* Letter from the Chair (Required for all applicants) Please refer to the description of the Chair letter described for the Pathway type to which you wish to apply. https://professional.diabetes.org/meetings/pathway-stop-diabetes%C2%AE

DRAFT of your Research Strategy (4-page maximum) The research strategy should provide a high-level description of your scientific question(s) and the strategy(ies) and approach(es) that you will employ to address this question. It should be written with a level of detail appropriate for reviewers who are knowledgeable of the field, but who may not be directly involved in the proposed area of research. The research strategy section is flexible in format and does not require a detailed project plan, description of methods or preliminary data. Figures are allowed, but must be included in the 4-page limit. The research strategy should address the following components:

a) Scientific question(s)/specific problem(s) to be addressed

b) Specific approach(es) that will be employed

c) Significance and potential impact of the work

d) The potential risks and challenges, and how they will be overcome

References may be included, but may not exceed 1 page and are not included in 4 page limit. Applications exceeding any of these limits will be administratively disapproved.

Please identify which Pathway award type to which you are applying.

Please submit internal materials through My Research Proposal. (Code ILN)  https://www.grantinterface.com/Common/LogOn.aspx?eqs=ApVvmgXCk2Uj7AzWyDE...

Instructions for creating an account (if needed) and submitting your materials: https://www.ctsi.duke.edu/myresearchproposal

 

 

Internal Deadline

May 1, 2019

External Deadline

July 1, 2019